# China NMPA Product Recall - Flushing suction equipment

Source: https://www.globalkeysolutions.net/records/china_product_recall/gimmi-gmbh/7d9d086d-8fe4-47a8-9379-729dea575058/
Source feed: China

> China NMPA product recall for Flushing suction equipment by GIMMI GmbH published January 10, 2018. Recall level: Level 3 Recall. GIMMI GmbH, through its agent Stryker (Beijing) Medical Devices Co., Ltd., initiated a voluntary Cla

---

## Details

- Record Type: CHINA_PRODUCT_RECALL
- Title: GIMMI GmbH voluntarily recalls flushing and suction equipment
- Company Name: GIMMI GmbH
- Publication Date: 2018-01-10
- Product Name: Flushing suction equipment
- Recall Level: Level 3 Recall
- Recall Reason: The instructions for the flushing and suction equipment contained inaccurate or inadequate descriptions of the tubing, which could lead to improper product handling. Therefore, the manufacturer deemed these instructions unsafe and revised them accordingly.
- Discovering Company: Stryker (Beijing) Medical Devices Co., Ltd.
- Manufacturing Company: GIMMI GmbH
- Summary: GIMMI GmbH, through its agent Stryker (Beijing) Medical Devices Co., Ltd., initiated a voluntary Class III recall of its irrigation and suction equipment (Model T.5100.40) on December 29, 2017, as reported by the National Medical Products Administration (NMPA) on January 10, 2018. The primary issue identified was a critical deficiency in the product's instructions for use (IFU). Specifically, the IFU lacked sufficient handling information or provided inaccurate descriptions concerning the cleaning and disinfection of the equipment's tubing. This oversight presented a potential risk of improper product handling, leading to safety concerns. The recall affects 20 units in China across all batches, though the recall scope is global. Under the regulatory oversight of the NMPA, GIMMI GmbH is required to undertake several corrective actions. These include sending official recall notices to all affected customers to inform them of the safety concerns and the necessary steps. Furthermore, the company must file the revised, updated instructions for use with the NMPA for formal approval. Upon receiving NMPA approval, the new, corrected instructions for use will be distributed and accompany the product to ensure safe and proper usage by consumers and medical professionals alike. This proactive measure aims to mitigate any potential harm stemming from the previously inadequate instructions.

Company: https://www.globalkeysolutions.net/companies/gimmi-gmbh/e5e802cc-3f8b-43cc-9d11-c3acf74fbdfd/